Recombinant KLK1: the next step in stroke and preeclampsia treatment
With its lead candidate DM199, DiaMedica Therapeutics is advancing a recombinant form of KLK1 to res...
1232 Fourier DrMadison,
WI USA 53717
BellBrook Labs is dedicated to accelerating drug discovery and biological research. The company’s Transcreener® HTS enzyme assays, used by all of the major pharmaceutical companies, make it easy to screen thousands of different enzymes, including validated targets like kinases, as well as emerging targets like ATPases, GTPases, methyltransferases, cGAS, Helicases, and glycosyltransferases. Assay development and lead discovery services help customers advance targets through drug discovery programs with confidence.
With its lead candidate DM199, DiaMedica Therapeutics is advancing a recombinant form of KLK1 to res...
New research has discovered a key survival mechanism in metastatic melanoma, revealing that cancer c...
Researchers have discovered that pancreatic tumours evade the immune system by disguising themselves...
Unlock Exclusive Industry Insights